Transarterial chemoembolisation enhances programmed death-1 and programmed death-ligand 1 expression in hepatocellular carcinoma.

A, Montasser; A, Beaufrère; F, Cauchy; M, Bouattour; O, Soubrane; M, Albuquerque; V, Paradis

doi:10.1111/his.14317

Public

Transarterial chemoembolisation enhances programmed death-1 and programmed death-ligand 1 expression in hepatocellular carcinoma.

Shared by NobleBlocks on Mar 28, 2021 • 12:00 AM UTC

Authors:

Montasser A

Beaufrère A

Cauchy F

Abstract

Aims Immunotherapies represent a new alternative therapeutic approach for hepatocellular carcinomas (HCCs), and have shown promising results when used in combination therapy. The aim of this study was to evaluate the potential of transarterial chemoembolisation (TACE) to modulate programmed death-1 ...

Subject

Hepatocellular carcinoma

Immunotherapy

PD-L1

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!